Clinical Trial Update: Ocular Sarcoidosis Open Label Trial of ACTHAR Gel [NA]

View source ↗

Summary

Completed open-label trial of ACTHAR Gel for ocular inflammatory conditions with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Uveitis
• Ocular Sarcoidosis
• Panuveitis

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Ocular Sarcoidosis, Panuveitis | NA | Status: COMPLETED | Results posted: 2023-02-15